Uday Baldota

Rediff.com » News » Uday Baldota

News for Uday Baldota

Business

Sun Pharma eyes acquisitions in US

Domestic firm Sun Pharmaceuticals has prepared a war chest of $500 million for acquisitions in the US, as it bets big on the world's largest drugs market. "We want to acquire generic business in......

Sun Pharma keen to enter Japan's generics market

Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

India's Sun Pharmaceutical Industries Ltd plans to begin phasing out sales of generic drugs branded as Ranbaxy Laboratories Ltd products in the United States after completing a $3.2 billion......

Sun Pharma open to large acquisitions post Ranbaxy

India's largest drugmaker Sun Pharmaceutical Industries Ltd will look at making more large acquisitions even as it winds up a $3.2 billion deal to buy smaller rival Ranbaxy Laboratories Ltd. The......

Sun-Ranbaxy merger clears last hurdle

The merger gets Punjab & Haryana High Court go-ahead; deal to close after brand dilutions The $4-billion merger between Sun Pharmaceutical Industries and Ranbaxy Laboratories has crossed the final......

Uday Baldota

News for Uday Baldota

Sun Pharma eyes acquisitions in US

Sun Pharma keen to enter Japan's generics market

Post takeover, Sun Pharma to rebrand Ranbaxy drugs in the US

Sun Pharma open to large acquisitions post Ranbaxy

Sun-Ranbaxy merger clears last hurdle

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS